This is stated in a statement by the department on the Twitter page.
“Today, we have authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine for the prevention of coronavirus among children aged five to 11,” the report said.
It clarifies that the authorization was issued after a thorough and transparent evaluation of the vaccine.
According to the data of the regulator, the immune response of children of this age corresponded to that demonstrated by persons aged 16-25 years.
The effectiveness of the vaccine was 90.7% according to the results of a study among children 5-11 years old.
Earlier, the expert commission of the US medical regulator FDA made a recommendation for vaccination against coronavirus in children from five to 11 years old.
In July, Vitaly Zverev, a microbiologist, academician of the Russian Academy of Sciences, scientific director of the Mechnikov Research Institute of Vaccines and Serums, in an interview with URA.RU, emphasized the importance of achieving population immunity to coronavirus in the world.